Tag Archives: remdesivir

Moderna (MRNA) stock price has risen at the possibility of having a new coronavirus vaccine by the fall of this year. Trials are expected to have been completed in two months’ time.Moderna Inc (NASDAQ: MRNA) stock price has risen slightly today. The stock price is up to $28.11 +0.98 (3.61%) intraday. This rise in stock price is attributed to the expected positive results from the Moderna COVID-19 vaccine. The first results could be available in two months. Analysts believe that the trials...

As the search for COVID-19 vaccines intensifies, there are at least 20 coronavirus vaccines in the pipeline. However, Gilead Sciences (GILD) and Moderna (MRNA), the stocks of the leaders in the race, tumbled as the week came to the end.Coronavirus alias COVID-19 is the virus that has taken the humankind hostage for the past two months. It has led to most biotech companies to push beyond their limits in the search for a vaccine. As a result, the World Health Organization (WHO) officials...

Avigan, also known as Favipiravir, is a Japanese flu drug developed by the healthcare arm of Fujifilm. 340 patients taking the drug found it reduces recovery time and improves their lung condition. Enthralled by COVID-19, the world is waiting for a hero who will find the coronavirus vaccine. And one of the most widely-discussed variants to treat coronavirus today is Favipiravir (or Avigan). Worldwide famous biotech companies such as Gilead Sciences Inc (NASDAQ: GILD), Inovio Pharmaceuticals...

Let’s have a closer look at Gilead Sciences Inc (NASDAQ: GILD) and Moderna Inc (NASDAQ: MRNA) stocks as the companies are working on possible coronavirus vaccine.In the race for a coronavirus vaccine, two horses battle for the lead, Gilead Sciences Inc (NASDAQ: GILD) and Moderna Inc (NASDAQ: MRNA). As a result, a lot of speculation on the booming of their stock prices has been in the mainstream media, since the outbreak of the deadly virus.Gilead Sciences is an American public biotech company...

Gilead Sciences (GILD) stock price has moved up at the news that its drug remdesivir is used to treat coronavirus patients on ‘compassionate’ grounds.Gilead Sciences Inc (NASDAQ: GILD) stock has made some gains after the confirmation of the use of one of its drugs on U.S. soil. Sources say that Remdesivir is being used to treat several patients who have coronavirus. The drug is not approved by the U.S. Food and Drug Administration (FDA). Certain rules allow for the use of such mediations on...